Titanium Hearts: Electric Power For Lifelong Pulse

is a titanium heart powered by electricity

Heart failure affects over 10 million people in the US and Europe annually, and the demand for donor hearts far exceeds the supply. The development of a synthetic replacement for the heart has been a long-sought goal of modern medicine. In 2024, a titanium heart powered by electricity was implanted into a human being for the first time. The device, called the BiVACOR Total Artificial Heart (TAH), is designed to replace the full function of a human heart.

Characteristics Values
Material Titanium
Design BiVACOR TAH
Power Source External controller and batteries
Pump Type Rotary blood pump
Pump Operation Driven by a smart controller that adapts to changes in patient activity and cardiac output demand
Pump Construction One motor and a single magnetically levitated rotor
Pump Flow Rate >12 L/min
Use Case Temporary measure for patients waiting for a donor heart
Patient Freedom Increased compared to previous solutions as it does not require wearing a power box
Size Small enough to fit into a child
Durability Resistant to corrosion and mechanical wear

shunzap

The BiVACOR TAH is a paradigm shift in artificial heart design

The BiVACOR TAH is powered by a small, external, portable controller that exits through the stomach. It is designed to adapt to the physiological demands of the patient, increasing its output during exercise, for example. This adaptability is a significant advantage over previous artificial heart designs, which often required cumbersome power boxes that patients had to wear at all times.

The device's simple construction, with one motor and a single rotor, also sets it apart from current TAH technologies, which utilize volume displacement pump designs with flexible polymer diaphragms to pump blood. The lack of other moving parts in the BiVACOR TAH means that the rest of the heart can be made from ultra-robust titanium. This construction provides high biocompatibility and resistance to corrosion and mechanical wear.

The BiVACOR TAH is designed to address the global unmet need for patients with end-stage heart failure awaiting transplant. Heart failure affects over 10 million people in the US and Europe each year, and the demand for donor hearts far exceeds the supply. The BiVACOR TAH aims to provide a long-term therapy solution for these patients, with the potential to transform the future of heart failure treatment.

The first successful implantation of the BiVACOR TAH took place at Baylor St. Luke's Medical Center at the Texas Heart Institute. The device was implanted in a patient with end-stage heart failure, and it worked very well for eight days before a real donor heart became available. This successful implantation marked a significant milestone in the development of artificial hearts, with the potential to save many lives.

shunzap

The titanium heart is powered by rail tech

The titanium heart, known as the BiVACOR Total Artificial Heart (TAH), is a revolutionary device that utilizes rail technology to power its functions. This technology, known as maglev, involves magnetic levitation, which enables the device to have a single moving part—the rotor. By using this advanced technology, the titanium heart offers a smoother and more biocompatible alternative to traditional mechanical pumps with multiple moving components and mechanical valves.

The BiVACOR TAH is designed to replace the full function of a human heart and is constructed from titanium due to its high biocompatibility and corrosion resistance. It is a biventricular rotary blood pump that utilizes a magnetically levitated rotor to pump blood efficiently through the heart's chambers. The rotor replaces both ventricles of a failing heart and simultaneously pumps blood to the body and the lungs. This design innovation, with its simple construction, sets it apart from current TAH technologies that utilize volume displacement pump designs with flexible polymer diaphragms.

The titanium heart is powered by an external, portable controller that provides power to the internal device through a percutaneous driveline. This controller adapts to changes in patient activity and cardiac output demand, allowing the device to adjust its output according to the physiological demands of the patient. For example, it can pump faster during exercise to meet the increased demand for blood flow. The use of maglev technology also helps to minimize blood trauma and improve the overall performance of the artificial heart.

The development of the BiVACOR TAH represents a significant advancement in the field of heart transplants and artificial heart design. It offers a potential solution for patients suffering from severe biventricular or univentricular heart failure, providing a much-needed option for those with end-stage heart failure awaiting a donor heart. The device has been successfully implanted in patients, showcasing its feasibility and potential to transform the future of heart failure therapy.

shunzap

The titanium heart is a temporary solution for those awaiting a donor heart

The titanium heart, also known as BiVACOR TAH, is a groundbreaking innovation in the field of heart transplants. It is designed to serve as a temporary solution for patients awaiting a donor heart, revolutionizing the way heart failure is treated. Heart failure affects millions of people worldwide, and the demand for donor hearts far exceeds the supply, making it a dire situation for those waiting for a transplant. The titanium heart offers a glimmer of hope in these circumstances.

The BiVACOR TAH is a significant departure from traditional artificial heart designs. Unlike previous attempts that sought to replicate the pumping action of a real heart, BiVACOR utilizes a single spinning disc or rotor to drive blood to the lungs and the rest of the body. This magnetically levitated rotor is the only moving part within the device, eliminating mechanical wear and reducing the risk of complications. The simplicity of its construction is a key advantage, setting it apart from earlier artificial hearts that employed complex systems of pumps and valves, which were prone to rapid failure.

The titanium heart is powered by a small, external, portable controller that exits through the stomach. This controller adapts to the patient's physiological demands, allowing the device to pump faster during exercise and slower during rest. The titanium construction of the heart provides exceptional durability, corrosion resistance, and biocompatibility. The device is small enough to fit into adults and children, making it a versatile option for a diverse range of patients.

While the titanium heart has shown promising results in initial human trials, it is still considered a temporary solution. The first recipient of the BiVACOR TAH, a 58-year-old man with end-stage heart failure, relied on the device for eight days before receiving a donor heart transplant. The titanium heart successfully sustained him during this waiting period, showcasing its effectiveness as a bridge-to-transplant solution. Further studies and trials are underway to assess the safety and long-term performance of the BiVACOR TAH, with the potential to transform the lives of countless individuals facing heart failure.

The development of the titanium heart represents a significant milestone in the quest for a fully functional and durable artificial heart. While it is not intended to replace the heart permanently, it provides a crucial stopgap measure for patients awaiting donor hearts. The success of the titanium heart in human trials offers renewed hope and extended life to those facing the daunting challenge of heart failure, marking a paradigm shift in the field of cardiovascular medicine.

shunzap

The titanium heart is designed to replace the full function of a human heart

The titanium heart, also known as BiVACOR Total Artificial Heart (TAH), is a revolutionary design in the field of heart transplants. It is designed to replace the full function of a human heart, providing a long-term solution for patients with end-stage heart failure.

The titanium heart is constructed from titanium due to its high biocompatibility and corrosion resistance. It features a single, magnetically levitating rotor that simultaneously pumps blood to the body and the lungs. This design innovation allows for a simple construction, with one motor and no flexible chambers, pumping diaphragms, or mechanical bearings. The lack of multiple moving parts results in minimal mechanical wear, enhancing the durability of the device.

The titanium heart is powered by a small, external, portable controller that exits through the stomach. This controller adapts to changes in patient activity and cardiac output demand, allowing the device to adjust its output according to the physiological demands of the patient. For example, it can increase pumping speed during exercise. This adaptability makes it suitable for both adults and children.

The titanium heart represents a significant advancement in heart transplantation technology. Traditional artificial hearts often relied on cumbersome power boxes and wiring, which increased the risk of infection. In contrast, the titanium heart offers a smoother and more biocompatible alternative with its advanced MAGLEV technology. This technology, adapted from high-speed rail lines, enables efficient blood flow with minimal blood trauma and reduced mechanical wear.

The titanium heart has undergone successful implantation in a human patient, marking a world-first achievement. The procedure was performed at Baylor St. Luke's Medical Center at the Texas Heart Institute, where a patient with end-stage heart failure received the titanium heart as a temporary measure until a donor heart became available. The titanium heart functioned successfully for eight days before the patient received a real donor heart transplant. This breakthrough paves the way for further transplants and offers hope to the millions of people affected by heart failure each year.

shunzap

The titanium heart is a bridge-to-transplant solution for patients with severe biventricular heart failure

The titanium heart, also known as the BiVACOR Total Artificial Heart (TAH), is a revolutionary device designed to address the global need for patients with end-stage heart failure awaiting transplant. This innovative technology is a bridge-to-transplant solution, providing life-extending support for those with severe biventricular heart failure.

Heart failure affects a significant number of individuals worldwide, with over 10 million people impacted in the US and Europe annually. The demand for donor hearts far exceeds the supply, leaving patients with limited options and a bleak outlook. The titanium heart offers a glimmer of hope in this challenging landscape.

The titanium heart is a significant advancement in artificial heart design. Unlike traditional mechanical pumps, it utilizes a single spinning disc or rotor, magnetically levitated within the device, to efficiently pump blood through the heart's chambers. This design minimizes blood trauma and enhances overall performance, addressing the complexities of emulating the human heart's functions with synthetic materials and power sources.

The titanium heart's construction is simple yet robust. It is made from ultra-robust titanium, known for its high biocompatibility and corrosion resistance. The lack of multiple moving parts and mechanical valves further enhances its durability. The device is small enough to fit into most adults and even children, adapting its output to meet the physiological demands of the patient.

The titanium heart has already proven its effectiveness in a real-world setting. In one notable case, a 58-year-old man in the United States became the first person to receive the titanium heart as a temporary measure. The device successfully sustained him during his daily activities for eight days until a donor heart became available. This groundbreaking achievement highlights the potential of the titanium heart as a bridge-to-transplant solution, offering patients a new lease of life while they await a donor organ.

Frequently asked questions

A titanium heart is an artificial heart made from titanium.

The titanium heart called BiVACOR Total Artificial Heart (TAH) is powered by a small, external, portable controller that exits through the stomach. It uses a single spinning disc to drive blood to the lungs and body.

An Australian man in his forties survived with a titanium heart for 100 days. Another man survived for eight days with the BiVACOR TAH before receiving a real donor heart.

The purpose of a titanium heart is to act as a bridge-to-transplant solution for patients with severe biventricular heart failure or univentricular heart failure.

Written by
Reviewed by

Explore related products

Share this post
Print
Did this article help you?

Leave a comment